Analyst Recommendations

Raymond James analyst issues OUTPERFORM recommendation on RXT at 2023-09-19 02:48:00. The previous analyst recommendation was Market Perform.At the time of the issue of the analyst recommendation, the

September 20, 2023   RXT 3.13%

Wolfe Research analyst issues OUTPERFORM recommendation on REXR at 2023-09-19 03:13:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the REXR...

September 20, 2023   REXR -0.34%

Wedbush analyst issues OUTPERFORM recommendation on DAVA at 2023-09-19 02:45:00. The previous analyst recommendation was Outperform.At the time of the issue of the analyst recommendation, the DAVA was...

September 20, 2023   DAVA -1.72%

Daiwa analyst issues OUTPERFORM recommendation on DELL at 2023-09-19 03:23:00. The previous analyst recommendation was .At the time of the issue of the analyst recommendation, the DELL was...

September 20, 2023   DELL 1.80%

Citigroup analyst issues BUY recommendation on DAVA at 2023-09-19 02:45:00. The previous analyst recommendation was Buy.At the time of the issue of the analyst recommendation, the DAVA was...

September 20, 2023   DAVA -1.72%

Morgan Stanley analyst issues OVERWEIGHT recommendation on DAVA at 2023-09-19 02:45:00. The previous analyst recommendation was Overweight.At the time of the issue of the analyst recommendation, the DAVA...

September 20, 2023   DAVA -1.72%

Deutsche Bank analyst issues HOLD recommendation on DAVA at 2023-09-19 02:45:00. The previous analyst recommendation was Hold.At the time of the issue of the analyst recommendation, the DAVA...

September 20, 2023   DAVA -1.72%

Telsey Advisory analyst issues OUTPERFORM recommendation on COST at 2023-09-18 14:31:00. The previous analyst recommendation was Outperform.At the time of the issue of the analyst recommendation, the COST...

September 18, 2023   COST 2.76%

William Blair analyst issues OUTPERFORM recommendation on GSK at 2023-09-18 13:59:00. The previous analyst recommendation was Outperform.At the time of the issue of the analyst recommendation, the GSK...

September 18, 2023   GSK 1.58%

Credit Suisse analyst issues OUTPERFORM recommendation on EMN at 2023-09-18 13:28:00. The previous analyst recommendation was Outperform.At the time of the issue of the analyst recommendation, the EMN...

September 18, 2023   EMN -0.04%